NY-ECOVATIVE
Ecovative announced today that it is opening access to a major European patent to all individuals and businesses who wish to use its MycoComposite™ mycelium materials in their own innovations and businesses in Europe. The company’s renewable material offers a nontoxic, planet-friendly alternative to plastics and other fossil fuel-derived materials.
Ecovative’s MycoComposite invention enables the manufacturing of products that are free of forever chemicals and other toxic substances like formaldehyde. This patent outlines a strategic blueprint for the creation of eco-friendly and renewable mushroom mycelium composites, offering a promising solution to curtail CO2 emissions across diverse industries and combat the escalating climate crisis.
"The goal of Ecovative has always been to provide the 'picks and shovels' for a new generation of businesses realizing the potential of mycelium technology," says Ecovative co-founder and CEO Eben Bayer. "The growing demand for environmentally beneficial products and processes is creating immense new opportunities not to reinvent the wheel, but to change what the wheel is made of, and we're excited to see the new discoveries and scalable solutions made with this versatile technology, for the benefit of Spaceship Earth."
The European Open Patent Program for MycoComposite is intended to encourage innovation in plastic-free products. The patent is already in use around the world in protective packaging, construction materials, architecture and innovative applications to replace petrochemical use. Several successful businesses have already been launched using MycoComposite, notably Loop Biotech which makes a popular line of mycelium coffins and urns.
"Loop Biotech has seen firsthand the huge demand for innovative, planet-friendly solutions enabled by mycelium materials," said Bob Hendrikx, founder of Loop Biotech, which uses MycoComposite material to produce sustainable coffins and urns. "I started this company to help humanity leave a positive footprint on the Earth, which is only possible when we collaborate with living organisms like fungi."
A sharp rise of interest in Europe for entrepreneurial applications of MycoComposite make it an ideal environment to test the potential of open access patents to spur an increase in innovations and businesses around mycelium technology. MycoComposite licensing and partnership opportunities will continue to be available outside of Europe supported by Ecovative’s state-of-the-art spawn and substrate facilities. The company owns numerous patents and patent applications related to mycelium manufacturing and product development globally.
Learn more about the program to open the MycoComposite European patent and what it means for the future of mycelium technology.
About Ecovative:
Ecovative is a biological science and design company, advancing mycelium technology to transform industries with high quality, Earth-friendly materials. Founded in 2007, Ecovative makes mycelium materials and products commercially competitive and accessible to everyone. Leveraging its Mycelium Foundry, dedicated production capacity and a range of industry leading partners, Ecovative grows better materials for everyday needs. To learn more, visit ecovative.com.
About MycoComposite:
MycoComposite is a combination of only two ingredients, mushroom mycelium and shredded plant fibers, such as kenaf, hemp stalks, and other plant-based waste from agriculture. The mycelium binds the material together into a natural composite that is highly versatile and earth-friendly in a range of applications. The process requires little energy and the final product is 100% bio-based returning nutrients to the Earth.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230926346447/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans13.5.2025 08:00:00 CEST | Press release
TreeFrog Therapeutics is the first company to present publicly a clinical-ready delivery strategy for 3D format microtissues in cell therapy.After four years in development, the validated device and delivery strategy overcomes challenges of 3D formats and uses existing stereotactic components to support adoption through ease of delivery education. TreeFrog Therapeutics, a French biotech specializing in cell therapy is the first company to present a clinical-ready delivery strategy for 3D microtissues cell therapy. The validated approach was demonstrated for their 3D neural microtissues cell therapy treatment for Parkinson’s disease. Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a progressive disease characterized by the loss of dopaminergic neurons with a mix of motor symptoms (bradykinesia, rigidity, resting tremor) and non-motor symptoms (cognitive deficits, mood disorders, fatigue). Current treatments provide symptomatic re
Ohana Development Launches ‘Jacob & Co. Beachfront Living by Ohana,’ A Masterpiece of Beachfront Elegance in the UAE13.5.2025 08:00:00 CEST | Press release
Valued at USD 1.3 billion, the project offers world-class amenities, including a signature Jacob & Co. ceiling art timepiece, the largest of its kind globally. Ohana Development, the leading real estate developer renowned for its luxury properties, has launched ‘Jacob & Co. Beachfront Living by Ohana’ in partnership with luxury timepiece and jewellery house Jacob & Co. The project was revealed at Emirates Palace Mandarin Oriental, Abu Dhabi. Located in Al Jurf between Dubai and Abu Dhabi, this USD 1.3 billion development blends natural surroundings with exceptional artistry and craftsmanship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512533615/en/ Jacob & Co. Beachfront Living by Ohana. (Photo: AETOSWire) Jacob & Co. Beachfront Living by Ohana presents 457 residences comprising of sea-view apartments, villas, penthouses, Sky Mansions, and beachfront mansions—each capturing the spirit of refined coastal living. Pentho
Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders13.5.2025 07:00:00 CEST | Press release
Financing round led by Jeito Capital and co-led by Forbion Growth, with participation from Seroba, Pictet Group and other existing investorsProceeds to fund two Phase 3 pivotal programs with nizubaglustat, lead asset in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses as well as expanding the Azafaros pipeline to other indicationsNizubaglustat has been awarded Orphan Drug Designation in both the US and Europe as well as Fast-track status in the US. The company expects to initiate both Phase 3 studies later this year Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of an oversubscribed €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and with additional participation from Seroba, Pictet Group and existing investors Forbion Ventures, Schroders Capital and BioGeneration Ventures (BGV). This financing enables Az
Presidio Investors is Pleased to Announce the Addition of Christian Schütte as Its Newest Operating Partner12.5.2025 19:04:00 CEST | Press release
Christian brings more than 20 years of global experience in investment banking, private equity, and operational leadership, with a proven track record of driving transformational growth across industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512473756/en/ Christian Schütte Christian began his career at J.P. Morgan in New York and London, where he worked in the M&A and Corporate Finance teams. He later joined Fortress Investment Group and was instrumental in launching its German operations. During his tenure, he helped raise over €1.5 billion in equity and managed a wide array of investments, including non-performing and performing loans, private and public companies. He went on to join EQT Group, where he focused on mid-market growth and succession investments. Notably, he led the consolidation of nine digital marketing agencies into a €100 million market leader, building one of the most comprehensive digital ma
Introducing Joblio – The Future of Ethical Recruitment12.5.2025 18:30:00 CEST | Press release
Joblio Launches to Revolutionize Ethical Recruitment and End Worker Exploitation Joblio, a global ethical recruitment platform, officially launches today to tackle the broken labor migration system—long plagued by exploitative intermediaries, high recruitment fees, and human rights abuses. With its tech-driven model, Joblio connects vetted workers with employers directly, eliminating unethical middlemen and ensuring cost-free hiring for migrant workers. Employers fund access to talent, but workers never pay—a key step in ending exploitation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512628048/en/ A Mission Rooted in Personal Experience Joblio is led by Jon Purizhansky, a refugee-turned-entrepreneur who experienced migration challenges firsthand. Forced to flee his home country as a young man, Jon faced the uncertainty and vulnerability that millions of migrant workers still encounter today. Now a globally recognized
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom